Change in Cone Structure Over 24 Months in USH2A-Related Retinal Degeneration.


Journal

American journal of ophthalmology
ISSN: 1879-1891
Titre abrégé: Am J Ophthalmol
Pays: United States
ID NLM: 0370500

Informations de publication

Date de publication:
08 2023
Historique:
received: 22 12 2022
revised: 01 03 2023
accepted: 07 03 2023
medline: 17 7 2023
pubmed: 23 3 2023
entrez: 22 3 2023
Statut: ppublish

Résumé

To describe cone structure changes using adaptive optics scanning laser ophthalmoscopy (AOSLO) in the Rate of Progression of USH2A-related Retinal Degeneration (RUSH2A) study. Multicenter, longitudinal natural history study. AOSLO images were acquired at 4 centers, twice at baseline and annually for 24 months in this natural history study. For each eye, at least 10 regions of interest (ROIs) with ≥50 contiguous cones were analyzed by masked, independent graders. Cone spacing Z-scores, standard deviations from the normal mean at the measured location, were compared between graders and tests at baseline. The association of cone spacing with clinical characteristics was assessed using linear mixed effects regression models weighted by image quality score. Annual rates of change were calculated based on differences between visits. Fourteen eyes of 14 participants were imaged, with 192 ROIs selected at baseline. There was variability among graders, which was greater in images with lower image quality score (P < .001). Cone spacing was significantly correlated with eccentricity, quality score, and disease duration (P < .02). On average, the cone spacing Z-score increased 0.14 annually (about 9%, P < .001). We observed no significant differences in rate of change between disease type (Usher syndrome or retinitis pigmentosa), imaging site, or grader. Using current methods, the analysis of quantitative measures of cone structure showed some challenges, yet showed promise that AOSLO images can be used to characterize progressive change over 24 months. Additional multicenter studies using AOSLO are needed to advance cone mosaic metrics as sensitive outcome measures for clinical trials. NOTE: Publication of this article is sponsored by the American Ophthalmological Society.

Identifiants

pubmed: 36948373
pii: S0002-9394(23)00103-4
doi: 10.1016/j.ajo.2023.03.006
pii:
doi:

Substances chimiques

USH2A protein, human 0
Extracellular Matrix Proteins 0

Types de publication

Multicenter Study Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

77-93

Subventions

Organisme : NEI NIH HHS
ID : P30 EY002162
Pays : United States
Organisme : Foundation Fighting Blindness
ID : RUSH2A - CONSORTIUM - 2016
Pays : United States

Informations de copyright

Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved.

Auteurs

Jacque L Duncan (JL)

University of California, San Francisco, CA, USA. Electronic address: jacque.duncan@ucsf.edu.

Wendi Liang (W)

Jaeb Center for Health Research, Tampa, FL, USA.

Maureen G Maguire (MG)

Jaeb Center for Health Research, Tampa, FL, USA.

Travis C Porco (TC)

University of California, San Francisco, CA, USA.

Jessica Wong (J)

University of California, San Francisco, CA, USA.

Isabelle Audo (I)

Quinze Vingts National Ophthalmology Hospital, Paris, France.

Jenna A Cava (JA)

Medical College of Wisconsin, Milwaukee, WI, USA.

Kate Grieve (K)

Quinze Vingts National Ophthalmology Hospital, Paris, France.

Angelos Kalitzeos (A)

Moorfields Eye Hospital, London, UK.

Joseph Kreis (J)

Medical College of Wisconsin, Milwaukee, WI, USA.

Michel Michaelides (M)

Moorfields Eye Hospital, London, UK.

Nathaniel Norberg (N)

Quinze Vingts National Ophthalmology Hospital, Paris, France.

Michel Paques (M)

Quinze Vingts National Ophthalmology Hospital, Paris, France.

Joseph Carroll (J)

Medical College of Wisconsin, Milwaukee, WI, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH